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The understanding of the interaction between the membrane of neurons and Amyloid-β peptides is of crucial importance 9 
to shed light on the mechanism of toxicity in Alzheimer disease. This paper describes how supercritical angle fluorescence 10 
spectroscopy was applied to monitor in real-time the interaction between a supported lipid bilayer (SLB) and the peptide. 11 
Different forms of Amyloid-β (40 and 42 amino acids composition) were tested and the interfacial fluorescence was 12 
measured to get information about the lipid integrity and mobility. The results show a concentration-dependent damaging 13 
process of the lipid bilayer. Prolonged interaction with the peptide up to 48 hours lead to an extraction and clustering of 14 
lipid molecules from the surface and a potential disruption of the bilayer, correlated with the formation of peptide 15 
aggregates. The natural diffusion of the lipid was slightly hindered by the interaction with Amyloid-β(1-42) and closely 16 
related to the oligomerization of the peptide. The adsorption and desorption of Amyloid-β was also characterized in terms 17 
of affinity. Amyloid-β(1-42) exhibited a slightly higher affinity than Amyloid-β(1-40). The former was also more prone 18 
to aggregate and to adsorb on the bilayer as oligomer.  19 
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 21 
1. INTRODUCTION 22 
Functions of proteins and polypeptide chains are intrinsically based on their three-dimensional structure. Whatever the 23 
structure is, it is reached in vivo in a short time scale after the synthesis of the molecule, driven by stabilizing non-covalent 24 
interactions between the amino acids1,2. This process is referred to as protein folding. However, incorrect conformations 25 
might be the result of improper folding and be stable enough to hinder any restructuration toward the correct functional 26 
structure3. These “misfolded” polypeptides are likely to promote health troubles either by canceling necessary biological 27 
functions or gaining toxic properties4. Misfolded or disordered polypeptides sometimes aggregate into a specific structure 28 
called “amyloid fibril”. This amyloid fibril is characterized by a stack of β-sheet strands forming a cross-β structure 29 
perpendicular to the axis of fibril growth5,6. Several diseases are correlated to the formation and deposition of such amyloid 30 
structure, either intra or extracellular5,7,8. Among them, Alzheimer is a neurodegenerative disease of particular interest and 31 
is recognized by extracellular deposition of aggregated amyloid-β peptides (Aβ) as plaque composed of amyloid fibrils 32 
surrounding the neurons9.  33 
Aβ is a small peptide generated by the cleavage of a transmembrane protein called amyloid-β precursor protein (APP). 34 
The resulting Aβ fragments vary in their length but the most commonly found in Alzheimer plaque count 40 or 42 amino 35 
acids10,11. The native structure of Aβ is usually described either as a random coil in aqueous solution12 or as a small α-helix 36 
when interacting with membrane or hydrophobic surfaces13,14. According to recent theories, the small oligomers formed in 37 
the early stage of aggregation are supposed to be more toxic for the neurons than the late fibrillar aggregates which 38 
constitute the extracellular plaque15–17. However, the direct cause for toxicity remains unclear. Different effects have been 39 
observed following the aggregation of the peptides and could explain the neuronal death encountered in the brain of disease 40 
patients. These effects include the oxidation of the lipid molecules in the membrane18,19, hindrance of the lipids mobility 41 
within the bilayer20 and formation of pore-like channels through the membrane of cells15,21,22.  42 
Different in vitro lipid structures have been established to study the impact of their interaction with peptides, assuming 1 
that these models can partially mimic the response of neuron membrane in vivo23,24. Among these models, supported lipid 2 
bilayers (SLB) are planar fluid membranes formed by deposition and fusion of unilamellar vesicles (ULVs) onto 3 
hydrophilic substrates25. SLBs are easily formed on a support and are attractive due to their simplicity compared to cell 4 
membranes. Furthermore, their formation takes place directly on an interface between the support and the sample medium. 5 
This last feature makes the SLB model particularly suitable for surface sensitive techniques since the interaction with 6 
peptides will occur only within this interfacial region. Supercritical angle fluorescence (SAF) is one of these selective 7 
techniques. It allows to distinguish between fluorophores emitting a signal from the interface and those which are diffusing 8 
in the bulk solution, without the need of any washing steps to remove unbound molecules. Therefore, real-time monitoring 9 
of interaction processes is possible including recording kinetic data. This is achieved by specifically collecting the 10 
fluorescence coming from above the angle of total internal reflection (critical angle) of a glass-water interface, essentially 11 
emitted by the fluorophores situated near such an interface. Therefore, it excludes almost all fluorescence which is emitted 12 
beyond a range of ~200 nm from the surface26,27. In addition, undercritical angle fluorescence (UAF) can be collected 13 
simultaneously. This signal corresponds to the output of a traditional confocal microscope. It allows to detect fluorophores 14 
emitting from the bulk solution with a collection efficiency extending up to ~2.5 µm above the interface28.   15 
The simultaneous detection of SAF and UAF signal even allows the precise determination of the position of an emitter in 16 
the axial direction from the surface, i.e. a precision down to a few nanometers. This technique has been already applied to 17 
study the interaction of α-synuclein29. SAF has also been developed for special fluorescence methods, e.g. SAF-FRET and 18 
SAF-FCS30. The SAF/UAF technique was used in this study to investigate the interaction between a negatively charged 19 
SLB and two different Aβ 40 and 42 amino acids long peptides, referred to as Aβ(1-40) and Aβ(1-42) respectively. Among 20 
these peptides, Aβ(1-42) was assumed to be potentially more toxic since it would have a higher propensity to aggregate 21 
into oligomers31. 22 
 23 
2. RESULTS AND DISCUSSION 24 
2.1 Adsorption affinity of the peptides.  25 
In a first experiment we studied in real-time the affinity of Aβ to SLBs by SAF. In order to quantify the early-stage 26 
adsorption, non-fluorescent SLBs were incubated with fluorescently labelled peptide solutions (Aβ (1-40) and Aβ (1-42)). 27 
Similar fluorescent labels were proven by Quinn et al. to yield analogous structures for aggregated Aβ and the unlabelled 28 
peptides32,33. Furthermore, in each sample only 1% of the peptides added were fluorescently labelled. Such amount limited 29 
the influence of the label moieties on the aggregation of other peptides. It also prevented fluorescence self-quenching and 30 
provided satisfying signal. Because the SAF channel only transmits photons arising from the interface, the signal was 31 
considered as the emission of SLB-bound peptides only. The SAF signal was monitored over a certain area for different 32 
peptide concentrations ranging from 1 µM to 40 µM during at least 6 hours after the beginning of the incubation. The 33 
intensity of fluorescence was averaged over the complete area of each scan. The change in fluorescence intensity recorded 34 
from the SAF channel was plotted as a function of the incubation time (Fig. 1 a). Results revealed a particular evolution 35 
of the signal divided in two time-ranges. For an incubation time up to 30 minutes, all protein solutions showed a fast 36 
increase in fluorescence intensity, followed by a systematic decrease in intensity. These results are interpreted as a fast 37 
adsorption of the peptides followed by a partial desorption due to weak unspecific interactions. This behavior is well known 38 
as “overshooting” and known also from the adsorption of other proteins34–37. This time range is hereafter referred to as 39 
short-time adsorption (depicted by the red shade on Fig. 1 a). During the short-time adsorption, Aβ (1-40) displayed a 40 
higher fluorescence signal than its more toxic counterpart Aβ (1-42) for concentrations between 1 µM and 5 µM (Fig. 1 41 
b). However, this tendency was reversed beyond 10 µM, namely at concentration equal or superior to the critical micellar 42 
concentration (cmc) of both Aβ’s38. Around and beyond cmc range Aβ (1-42) is known to exist as higher order aggregates 43 
than Aβ (1-40). This explains its subsequent higher fluorescence intensity during overshooting since the first adsorbed 44 
peptides are bigger aggregates (cfr. supporting information, S1). Once the minima of SAF intensity have been reached 45 
after the overshooting effect described previously, extended time of adsorption yielded in different behavior for each type 46 
of peptide. Aβ (1-40) exhibited either a plateau or a slow increase when the time of incubation was prolonged beyond 24h.  47 
 1 
Figure 1. Evolution of the SAF signal after incubation with fluorescent peptides. (a) Long-time adsorption of Aβ (1-40) and Aβ (1-42). 2 
Short-time adsorption is highlighted in red. (b) Short-time adsorption/overshooting period of Aβ (1-40) and Aβ (1-42). (c) Comparison 3 
between SAF/UAF imaging of 5 µM Aβ (1-40) and Aβ (1-42) after 4 hours of incubation. (d) Maxima of fluorescence intensity after 6 4 
hours of incubation as a function of Aβ concentration.  5 
On the other hand, Aβ (1-42) showed a further increase in fluorescence intensity after only one hour. Aβ (1-42) exhibits 6 
several irregular jumps of intensity before reaching another plateau. SAF imaging of the surface area allowed to correlate 7 
these fluctuations with the appearance of fluorescent aggregates on the SLB (Fig. 1 c). On the UAF imaging, bright stripes 8 
are visible which are attributed to the motion of these fluorescent aggregates in the bulk solution during the scanning 9 
process. Some of them will eventually adsorb durably on the interface and increase the SAF intensity. Also, some of the 10 
aggregates were less intense or seemingly absent from the UAF channel. This situation corresponds to fluorophores 11 
detected closer from the interface, whose fluorescence radiations are mostly sent above the critical angle27. The part of 12 
their emission which is detected under the critical angle (UAF) is therefore smaller and they are harder to distinguish from 13 
the bulk fluorescence background. These fluorescent aggregates are thought to be the result of peptides oligomerization. 14 
As shown by the comparison of imaging between the two peptides, Aβ(1-42) exhibited a stronger and faster tendency than 15 
Aβ (1-40) to form these aggregates and nucleation sites of aggregation on top of the SLB after the short-time 16 
adsorption/desorption phase. This was especially obvious at concentrations above 5 µM. This outcome is in accordance 17 
with previous reports showing the higher propensity of Aβ (1-42) to aggregate, due to the influence of the longer C-18 
terminus 31. Therefore, the outstanding signal of Aβ(1-42) on the interface after long-time adsorption could have three 19 
explanations. It was either due to the adsorption on the SLB of peptide aggregates pre-formed in solution ; or caused by 20 
peptides stacking on aggregates already adsorbed ; and/or simply caused by an enhanced adsorption of monomers due to 21 
a higher affinity for the lipids. The quantification of Aβ(1-40) and Aβ(1-42) affinities was required to assess this hypothesis. 22 
To quantify the affinity of the peptides for the SLB, the maximum of average intensity of the area after 6h of adsorption 23 
was plotted as a function of peptide concentration (Fig. 1 d). This curve was then fitted with a Langmuir isotherm39 24 
(Equation 1). Fitting yielded values for the unspecific adsorption constant (Ku), which were then expressed as dissociation 1 
constant (Kd) to quantify this affinity (Equation 2).  2 
 3 𝐼𝐼 = 𝐼𝐼𝑚𝑚𝑚𝑚𝑚𝑚 𝐾𝐾𝑢𝑢 .  𝐶𝐶𝐾𝐾𝑢𝑢 .  𝐶𝐶+1                                                                                        (1) 4 𝐾𝐾𝑢𝑢 = 𝑘𝑘𝑎𝑎𝑘𝑘𝑑𝑑 =  1𝐾𝐾𝑑𝑑                                                                                  (2) 5 
where I is the measured fluorescence intensity, Imax is the maximum fluorescence intensity reached at higher concentration, 6 
and ka, kb being the kinetic constants for unspecific adsorption and desorption respectively. The values calculated for Kd 7 
were (4.24 ± 0.28) × 10-6 M for Aβ(1-40) and (3.48 ± 0.37) × 10-6 M for Aβ(1-42).  Despite the high limitation of the 8 
Langmuir isotherm model to describe protein adsorption events, the range of these values is in accordance with other 9 
studies40,41. From these data, it is supposed that the slightly higher Kd value for Aβ (1-40) reflects a weaker interaction 10 
with lipid molecules than Aβ(1-42). This could be expected for the less toxic type of peptide, although the difference of 11 
affinity is too small to justify the discrepancies in SAF. Despite having similar values for Kd, the Imax of each peptide is 12 
drastically different, as shown in Fig. 1 c: the maximum SAF intensity of Aβ(1-42) is almost 3-folds higher than its 13 
counterpart. During these experiments, Aβ(1-42) reached a higher SAF intensity than Aβ(1-40) when aggregates became 14 
visible on the interface. From that moment, the SAF intensity increased until a plateau is reached, demonstrating that the 15 
aggregates are adsorbed durably and not reversibly. Since our results yielded a similar affinity of both peptides for the 16 
lipids, this increase of surface fluorescence is likely the consequence of the deposition and subsequent growth of these 17 
aggregates. More Aβ(1-42)  adsorbed on the surface than Aβ(1-40) because they were in oligomeric state. So, the higher 18 
affinity of Aβ(1-42) for the SLB is nothing but a secondary factor to explain its higher SAF signal. The fact that Aβ (1-42) 19 
is the prior component of senile plaques in the brain42,43 supports the hypothesis that it aggregates more rapidly than Aβ(1-20 
40)  and interacts durably with the lipids at the early stage of the disease, while Aβ(1-40)  is slower to oligomerize. In the 21 
absence of oligomers, the maximum adsorption of non-aggregated peptides is limited by the saturation of the surface with 22 
monomers. The adsorption of monomers is also reversible at least at the initial (overshooting) period (i.e. desorption is 23 
observed up to 30 minutes of incubation). This limitation would explain why a non-aggregating Aβ(1-40) peptide yielded 24 
less signal than Aβ(1-42), prone to form oligomers. To confirm this supposition, the evolution and average intensity of the 25 
non-aggregated Aβ(1-42) layer was selectively monitored and compared with the data obtained from its aggregates (Fig. 26 
2 a).  27 
 28 
Figure 2. (a) Evolution of SAF intensity as a function of time for non-aggregated layer and aggregated sample of 10 μM fluorescent 29 
Aβ(1-42). (b) SAF imaging data with the tracking of the aggregates over time displayed by colored circles (each colored circle 30 
correspond to one of the aggregates which remain at similar location). The SAF intensity of the first aggregate (white circle) and non-31 
aggregated area (blue box) are displayed in (a). 32 
From its constant SAF value, it is clear that the layer of adsorbed non-aggregated Aβ is in equilibrium and saturation, 1 
respectively, with the incoming flow of peptides once the surface is saturated. Moreover, the SAF intensity of the non-2 
aggregated layer of Aβ(1-42) (Fig. 2 a, bottom line) is similar to the average SAF intensity of Aβ(1-40) in Fig. 1 a,c. This 3 
confirms that the presence of Aβ(1-42) aggregate is the main source for the discrepancies in maximum SAF intensity: 4 
without these aggregates, the two peptides would exhibit comparable SAF signal. Unlike the non-aggregated peptide areas, 5 
the fluorescent aggregates displayed in Fig. 2 b exhibited an increasing intensity. The aggregates are adsorbed tightly 6 
enough at the lipid bilayer so that most of them can be "tracked" by SAF imaging. This is represented in Fig. 2 b where 7 
each circle corresponds to the follow-up of one aggregate, a dashed circle indicating the same aggregate desorbs. They 8 
seemed to spread or desorb punctually, but the lateral position of many of them remained similar over a time-span of more 9 
than 2 hours. These measurements confirm the assumption that non-aggregated monomeric Aβ(1-40)  and Aβ(1-42) have 10 
a similar adsorption affinity. The different adsorption behavior of Aβ(1-40)  and Aβ(1-42) arises from the aggregates and 11 
not from the monomeric peptides. On the other hand, new interrogations came from the SAF imaging and tracking of the 12 
aggregates, whose motion seemed extremely limited. This might have been caused by an immobilization of the peptides 13 
on the glass surface, through the SLB. To check the latter hypothesis, the incubation of 10 µM Aβ(1-42) on SLB or on a 14 
bare glass slide was compared (cfr. supporting information, S2, S3). The more static aggregates were observed on both 15 
surfaces. But on average, the fluctuation of the fluorescent clusters indicated that only few peptides were totally 16 
immobilized on glass or on SLB. Comparison between bare glass and SLB also showed a net preferential adsorption of 17 
peptides on lipids. Therefore, it seems reasonable to assume that alterations of the membrane are caused by these 18 
interactions rather than by artefacts from peptides adsorbed on the glass slide.  19 
2.2 Impact of Aβ adsorption on fluorescently labelled SLBs. 20 
 21 
Figure 3. (a) Evolution of the SLB average fluorescence intensity over the time of incubation with 0.5 µM Aβ solutions. (right side) 22 
Comparison between SAF and UAF imaging of SLB after 24 h of incubation (b) without peptides (PBS only), (c) with 5 µM Aβ(1-40), 23 
(d) with 50 µM Aβ(1-40). The average SAF intensity of the SLB is displayed at the bottom right corner.  24 
To elaborate the impact of the Aβ adsorption on the SLB, the signal from a fluorescently-labelled SLB was monitored 1 
upon incubation with unlabeled peptides. Typically, images of the bilayer were recorded periodically in both SAF and 2 
UAF channels at different concentrations and at incubation times up to 48 hours. Three different effects could be observed, 3 
depending on the concentration of peptides: a decrease of the average SLB fluorescence intensity; the formation of 4 
fluorescent lipid aggregates; and eventually the disruption of the bilayer. At concentration between 0.5 and 5 µM, both Aβ 5 
(1-40) and Aβ (1-42) promote a decrease in SLB fluorescence intensity over time (Fig. 3 a). A lipid control confirmed that 6 
this effect was not only due to photobleaching or natural damaging but indeed reflected an influence of the peptides.  7 
When incubated with Aβ solutions of concentrations beyond 5 µM, the imaging displayed some fluorescent aggregates, 8 
attributed to the clustering of lipids (Fig. 3 c). The signal of these lipid clusters was more intense in the UAF than in the 9 
SAF channel. This interesting feature can be explained by a protrusion of the lipids growing beyond the interface and the 10 
maximum detection efficiency of SAF. Since the protocol for the formation of SLB (section 4.2) includes a washing of 11 
most of the unbound lipid vesicles, lipids clusters cannot be due to residual vesicles and are more likely formed from the 12 
interfacial lipids themselves which protrude above the bilayer. It is interesting to point out that the minimum Aβ 13 
concentration for the formation of these lipid clusters coincide with the minimum concentration at which peptide 14 
aggregates were observed (cfr. section 2.1). Therefore, this is an indication that peptide aggregation and lipid clustering 15 
are two concerted events. Besides the clustering of lipids, the formation of small dark areas in the SLB could be observed 16 
after approximately 20 hours of incubation with 50 µM of peptides. Such dark areas are attributed to a local desorption of 17 
the two lipid leaflets from the interface. These “holes” within the SLB had a diameter around 2-3 µm. The formation of 18 
smaller pores with a diameter size  of 16 nm have been reported after 20 min for Aβ directly mixed with liposomes44, 19 
which is beyond the lateral resolution of the microscope used in this study (550 ± 50 nm). Longer monitoring showed the 20 
holes spreading among the SLB and consequently resulted in a bilayer disruption. Beyond 24 hours of monitoring, a real 21 
disruption of the bilayer could be observed (Fig. 3 d). From these results it appears that a part of the toxicity of the two 22 
amyloidogenic peptides could arise from a progressive and concentration-dependent lipid removal process. The 23 
interactions with the peptides can induce an extraction of some lipid molecules from the bilayer, resulting in a decrease of 24 
fluorescence and thinning of the membrane when the lipid-peptide complex desorbs from the surface. These extracted lipid 25 
molecules can cluster due to the aggregation process between peptides encountered at higher concentration, assuming that 26 
each peptide maintains its interaction with extracted lipids while aggregating. At some point, the aggregated lipid-peptide 27 
structures may become too massive and unstable to withstand the flow of solution inside the measuring cell, hence being 28 
washed away and forming holes within the bilayer. These holes can eventually yield the disruption of the SLB (Fig. 4). 29 
This hypothesis is in agreement with other theories despite the discrepancies in SLB compositions, affinities or steady-30 
state experiments within these studies20,29.  31 
 32 
Figure 4. Scheme of the hypothesized mechanism of toxicity of Aβ upon interaction with a lipid bilayer. A progressive and 33 
concentration/aggregation-dependent lipid removal process leads to a thinning and potential disruption of the SLB 34 
 35 
In addition, these results were observed with two different SLB compositions, one including cholesterol. The only 1 
difference observed was the strength of the lipid-desorbing effect (cfr. supporting information, S4). Although a 2 
concentration of 50 µM Aβ is physiologically irrelevant45, lower concentration of the peptide also yielded a loss of 3 
fluorescence, which is still attributed to an extraction of lipid molecules. This effect could be sufficient to destabilize the 4 
structure of the membrane bilayer by reducing its thickness. Such event can hinder biological functions localized around 5 
the membrane and eventually promote cellular death.  6 
2.3 Evolution of the diffusion coefficient of lipids in SLB. 7 
Another important feature of lipid bilayers is the intrinsic mobility of lipid molecules and their lateral diffusion within the 8 
lipid leaflets46,47. Fluorescently labelled SLBs were studied by supercritical angle fluorescence correlation spectroscopy 9 
(SAF-FCS) upon incubation with peptides, using the signal detected by the SAF channel (cfr. supporting information, S5). 10 
Correlation plots were then fitted with a 2-dimensional diffusion model. Fitting allowed calculation of the diffusion 11 
coefficient (DL) which quantifies the lateral diffusion of lipid molecules (Equations 3, 4). Control values for SLB 12 
composition used in this study were in accordance with analogous data, considering discrepancies between the samples 13 
(~3-4×10-12m²s-1 for pure DOPC48 and ~2-3×10-12m²s-1 for DMPC49). FCS data of SLBs were recorded using different 14 
concentrations of Aβ peptide (Table 1). Most of Aβ samples had small impact on the mobility of lipid molecules during 15 
our experiments. Even at concentration as high as 50 µM, Aβ(1-40) did not influence the lateral diffusion of the lipids 16 
apart from the vicinity of the bilayer disruption. A possible explanation is provided by Ding et al. and their results of 17 
fluorescence recovery after photobleaching (FRAP) experiments, showing that the two DL values, of lipids and Aβ peptides 18 
respectively, were close50. Similarity between the speed of diffusion of the lipids and Aβ would explain why the peptide 19 
has minor influence on the lateral diffusion of the SLB in our experiments. However, the more toxic Aβ(1-42) induced a 20 
significant drop of the DL of our SLB at a concentration of  25 µM. In addition, Aβ(1-42) started to influence the diffusion 21 
of lipids after a minimum of 2 hours of incubation and it was known from previous results that after such a delay, Aβ(1-22 
42) would likely have formed aggregates on the surface of the SLB (cfr. section 2.1). It is supposed that the more massive 23 
aggregated species were able to slow down the diffusion of the lipids while smaller peptide species previously adsorbed 24 
had no influence. The fact that only Aβ(1-42), with a higher propensity to aggregate, exhibited a general impact on the 25 
diffusion of lipids support the oligomeric hypothesis. This can be regarded as another proof of the oligomeric nature of 26 
toxic Aβ, since the condition for the hindrance of the lipids diffusion coincides with the formation and adsorption of 27 
aggregated peptide species.   28 
Table 1. Values of the diffusion coefficient of SLB after 20 hours of incubation with Aβ peptide.  29 
DL  (10-12m²s-1) 0.5 µM Aβ(1-40) 5 µM Aβ(1-40) 50 µM Aβ(1-40) 0.5 µM Aβ(1-42) 5 µM Aβ(1-42) 25 µM Aβ(1-42) 
Before 
incubation 
2.88 ± 0.22 2.78 ± 0.27 2.91 ± 0.11 2.94 ± 0.42 2.69 ± 0.15 2.95 ± 0.38 
After 20 h 
incubation 
3.01 ± 0.10 3.06 ± 0.07 3.14 ± 0.05 2.91 ± 0.40 2.43 ± 0.06 1.90 ± 0.18 
 30 
2.4 Evolution of the diffusion coefficient of Aβ peptides. 31 
In addition to the mobility of the lipids, the diffusion of Aβ adsorbed at the SLB surface was also measured with fluorescent 32 
peptides. The data resulting from the SAF-FCS experiments were fitted to extract the diffusion coefficient. However, the 33 
diffusion of Aβ is not limited to the surface. In addition to a lateral diffusion on the surface of SLB, the motion of peptides 34 
also includes their adsorption and desorption from the surface. Therefore a 2-dimensional diffusion model was insufficient 35 
to evaluate their diffusion properly. Instead, a SAF-3-dimensional model was used. It was elaborated to include the 36 
exponential decay of detection of the supercritical angle technique along the axial axis30 as the peptides diffuse away from 37 
the interface. At a concentration of 5 µM the average diffusion coefficient of Aβ(1-40) was (24.85 ± 5.59) × 10-12 m2s-1 38 
while Aβ(1-42) had an average diffusion coefficient of (2.79 ± 0.49) × 10-12 m2s-1. It appears that the diffusion coefficient 39 
of Aβ(1-42) is in the range of the DL calculated for the SLB (table 1) while Aβ(1-40) diffused faster by one order of 40 
magnitude. Aβ(1-42) was previously identified as the peptide with a higher affinity for SLB and was adsorbed more tightly, 41 
therefore it could be appropriate that this peptide and the lipids diffuse with a similar speed. On the other hand, Aβ(1-40) 42 
is less tightly adsorbed and the amount of peptides within the detection volume fluctuates more rapidly due to faster 1 
adsorption/desorption processes. Quantitative comparison between the DL of the lipids and DL of Aβ should be made 2 
carefully since a 2-dimensional model was used to fit the diffusion of SLB, in contrast with the 3-dimensional SAF model 3 
used to fit the diffusion of Aβ. A simple qualitative analysis between the two types of peptide is more relevant, yet it shows 4 
explicitly that the SAF intensity of Aβ(1-42) fluctuates less than its shorter counterpart, hence the lower DL  for Aβ(1-42). 5 
The major contribution to the fluctuations of intensity is attributed to the adsorption/desorption process inside and outside 6 
of the detection volume, rather than a lateral diffusion at the surface of the bilayer. Discrepancies of this 7 
adsorption/desorption process between the two peptides can be explained by the difference of affinity for the SLB and the 8 
stability of peptide aggregates described in section 2.1. The FCS data obtained show a relation between the number of 9 
fluorescent emitters and the diffusion rate. Namely, Aβ(1-42) FCS data suggested a higher number of fluorophores than 10 
the signal observed from Aβ(1-40) in the monitored areas (cfr. supporting information, S6). Therefore, the slower diffusion 11 
of Aβ(1-42) correlates with a higher density of peptides on the surface, hence higher-order oligomers.  12 
2.5 Influence of calcium ions on the interaction between Aβ and SLB.  13 
The probable bidirectional relationship between Aβ and Ca2+ in Alzheimer disease has long been hypothesized51. Aβ can 14 
disturb Ca2+ homeostasis52, notably by formation of cation-selective channels, as mentioned earlier53,54.  On the other hand, 15 
dysregulation in the dynamics of Ca2+ ions can modify the brain metabolism and trigger the release of Aβ peptide55. 16 
Interactions between Aβ and Ca2+ also promotes the formation of oligomeric species56 and facilitates the binding of the 17 
peptide on the membrane57 via formation of ionic bridges. For all these reasons, the experiments described in previous 18 
sections have been repeated using PBS with 2 mM of CaCl2 ● 3H2O. The obtained results have been compared with those 19 
including Aβ dissolved in PBS.  20 
First, the monitoring of the adsorption of Aβ dissolved in membrane buffer was reproduced at low concentrations on a 21 
SLB. The average fluorescence of the monitored area was measured after 24 hours of incubation with the peptides. As a 22 
matter of fact, dissolution in membrane buffer increased the number of adsorbed peptides on SLB, compared with peptides 23 
dissolved in PBS (Fig. 5 a). This effect is thought to be the consequence of the interactions between Aβ and calcium ions. 24 
Computational studies explain this effect by the formation of the previously mentioned ionic bridge. Ca2+ is supposed to 25 
act as a link between the polar head group of the lipids and the peptides, negatively charged at neutral pH58. It also 26 
strengthens the electrostatic interactions between charged residues of Aβ and the SLB59. Ca2+ also enhanced the amount 27 
of aggregated species on the surface, even at concentrations as low as 200 nM (data not showed). This enhancement of 28 
peptide aggregation can be expected since the ion-bridge can also occur between two negatively charged peptides. However, 29 
the increase of fluorescent adsorbates due to calcium is only partially maintained beyond 2 μM peptides. Aβ(1-40) 30 
exhibited the highest enhancement of adsorption at concentrations of 1 and 2 µM, while Aβ(1-42) adsorption was only 31 
slightly strengthened at 5 µM. It is expected that beyond 2 μM, the concentration of peptides is sufficient for aggregation 32 
to occur in PBS solution without the influence of ion-bridge between Aβ. Therefore, the influence of aggregation on 33 
fluorescence intensity is not specific of Ca2+ buffer anymore. It is thought that the presence of Ca2+ can trigger the 34 
aggregation of Aβ and act as a bridge between the peptides and the lipid bilayer. However, the influence of this bridging 35 
effect on the adsorption is preponderant only at concentrations lower than 2 μM. Beyond this limit, the flux of peptides 36 
coming from the bulk solution toward the membrane is supposed to overcome the influence of the calcium. 37 
Furthermore, Ca2+ enhanced the decrease in the fluorescence of SLB observed when interacting with the peptides at 0.5 38 
µM (Fig. 5 b). This outcome has several possible explanations. As Ca2+ triggers the oligomerization of Aβ peptide at low 39 
concentration, it may promote more damaging within the SLB. Additionally, dynamic simulations showed that calcium 40 
ions stimulate a deeper insertion of Aβ inside the bilayer59, which correlates with a stronger disordering or thinning 41 
effect60,61. Another explanation is based on the previous conclusion that lipid removal is a concentration-dependent process. 42 
Since calcium ions increase the amount of adsorbed peptide – aggregated or not - the amount of extracted lipid molecules 43 
would be increased as well. Nevertheless, a conclusion similar to the previous adsorption experiment was drawn when the 44 
concentration of peptide was increased to 5 µM. At this concentration, the adsorption and aggregation features of Aβ were 45 
almost identical when dissolved in PBS or Ca2+ buffer, therefore the impact of the peptide on the SLB did not differ either, 46 
no matter in which buffer the peptide was dissolved. Finally, the influence of the peptide on the mobility of the lipid was 47 
measured by FCS. The values of DL  of the lipids after incubation with the peptide in the Ca2+ containing liquid phase are 48 
close to those obtained when Aβ is dissolved in PBS (Table 2). It was concluded in section 2.3 that the aggregation state 1 
of the peptides interacting with the SLB was the critical parameter to influence the diffusion of the lipids. The propensity 2 
to aggregate of such highly concentrated peptides interacting with the SLB seemed unaltered by the presence of Ca2+ ions, 3 
therefore no further reduction of the diffusion coefficient of SLB should be expected, as showed by the experiment.  4 
 5 
Figure 5. (a) Comparison of the adsorption of labelled peptide incubated over SLB in PBS and with Ca2+. (b) Comparison of the decrease 6 
in fluorescence intensity when labelled SLB are incubated with Aβ in PBS and with Ca2+. 7 
Table 2. Comparison of the diffusion coefficient of lipids inside SLB incubated with Aβ(1-42) in PBS and Ca2+ . 8 
DL  (10-12m²s-1) 5 µM Aβ(1-42) 
(in PBS) 
25 µM Aβ(1-42) 
(in PBS) 
5 µM Aβ(1-42) 
(+ 2 mM Ca2+) 
25 µM Aβ(1-42) 
(+ 2mM Ca2+) 
Before 
incubation 
2.69 ± 0.15 2.95 ± 0.38 2.78 ± 0.20 2.81 ± 0.32 
After 20 h 
incubation 
2.43 ± 0.06 1.90 ± 0.18 2.39 ± 0.17 2.04 ± 0.22 
 9 
2.6 Conclusion.  10 
In the present study the interaction between a lipid bilayer and two variants of Aβ peptides, responsible for Alzheimer 11 
disease, and also the effect of this interaction on the lipid molecules were investigated. Supercritical angle fluorescence 12 
microscopy was used in order to limit the detection volume to an area close to the bilayer interface. First, the adsorption 13 
of the peptides on SLB was monitored. From these results, the affinity of each could be calculated. Due to the absence of 14 
specific receptors in the bilayer, the interactions were considered as unspecific. As a matter of fact, the calculated values 15 
for Kd were in the range of low affinity interactions. Aβ(1-42) seemed to have a slightly higher affinity than the less toxic 16 
Aβ(1-40) after an incubation of a few hours, but mostly exhibited a higher tendency to form aggregates upon the bilayer. 17 
Further, the impact of such interactions on fluorescently labelled SLBs have been evaluated. Different effects were 18 
observed, depending on the concentration: a decrease of fluorescence intensity, a clustering of lipid molecules and 19 
eventually the progressive disruption of the bilayer. These effects were independent of which type of Aβ was incubated 20 
with the SLB. Despite the fact that these results were obtained with high concentration of peptides, they give an insight in 21 
the process which locally reduces the thickness of the bilayer and can make the cell membrane more fragile or even porous 22 
(Figure 4). The last step consisted to elaborate the effect of the peptides on the lateral lipid diffusion within the bilayer. 23 
Aβ(1-40) seemed to have no effect at all, while high concentration of Aβ(1-42) lead to a decrease in the mobility of lipids. 24 
Since the time of incubation, the concentration and the type of peptide required to affect DL of lipids all coincided with 25 
the conditions for maximum aggregation of Aβ, it seems that the hindrance of the diffusion of lipids is correlated with the 26 
adsorption of massive oligomeric species. Saturation of the surface with monomers or small oligomers (Fig. 2 b) seemed 27 
unable to affect the diffusion of the lipids. The diffusion of the peptides themselves is also a critical parameter, since only 1 
the slowest diffusing peptide Aβ(1-42) affected the diffusion within the SLB.  2 
In order to study the impact of calcium ions on these effects, experiments were repeated with Aβ(1-42) dissolved in a 3 
buffer containing 5 mM of Ca2+ instead of PBS. The results confirmed previous computational studies which reported an 4 
enhanced adsorption of the peptide on the lipids, probably due to the formation of ionic bridges, stronger electrostatic 5 
interactions and oligomerization. Calcium ions also increased the loss of fluorescence of labelled SLB incubated with Aβ. 6 
It was concluded that Ca2+   activates the toxicity of the peptide at low concentration, either by inducing oligomerization or 7 
through a deeper insertion within the bilayer. It would be interesting to investigate the latter effect by the use of neutron 8 
reflectometry. However, Ca2+ buffer did not yield any difference compared to PBS once the Aβ concentration was equal 9 
or superior to 5 µM and did not affect the influence of the peptide over the diffusion of the lipids at all. This result suggests 10 
that the aggregation process of the peptides was unchanged by Ca2+ beyond 5 µM. Therefore, the influence of Ca2+ in our 11 
experiments was limited at low concentration of peptides for which calcium actually increased the amount of adsorbed 12 
peptides, their aggregation and the potential disordering of the SLB. The influence of Ca2+ was lost once the concentration 13 
of peptide was high enough to yield aggregation in PBS. Higher damaging of SLB, correlated with aggregation at low 14 
concentration is another proof of the role of oligomers in the toxicity of Aβ. Eventually, the first stages of Alzheimer 15 
disease could correlate with the interactions of low concentrated Aβ with Ca2+ near the membrane of neurons. Since the 16 
toxic effects of the peptide disturb calcium homeostasis and the ions themselves trigger peptide release and adsorption, it 17 
could be a progressive degenerative cycle.  18 
3. METHODS  19 
3.1 Setup design 20 
A custom-made microscope objective was used to split the collected fluorescence arising from angles higher and lower 21 
than the critical angle. For a glass-water refractive index discontinuity, this critical angle (θc) is 61°, according to the 22 
formula θc = arcsin(nwater/nglass)62. Therefore, the objective is designed with an internal parabolic shaped lens able to collect 23 
radiation coming from above θc for aqueous sample or solution with the same refractive index than water (n = ~1.33). 24 
Undercritical angle light is transmitted through a collection of lenses whose numerical aperture is equal to 1.0, which is 25 
also used to focus the excitation light. The custom-made objective is mounted on an inverted Olympus IX71. The excitation 26 
light source is a power tunable diode laser emitting at 633 nm (TOPTICA iBeam Smart). Optical parts are assembled to 27 
drive the collected SAF/UAF fluorescence light simultaneously as two concentric collimated beams. They are separated 28 
afterwards toward their respective detector. The constant splitting between two detectors allows the comparison between 29 
the signals mentioned before. See the paper by Verders et al. for a detailed description of the optical setup28. 30 
3.2. Lipids and peptides handling 31 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) in 32 
chloroform were used as received (Avanti Polar Lipids). Fluorescently labelled 1,2-dioleoyl-sn-glycero-3-33 
phosphoethanolamine powder (DOPE-Atto647; Atto-tec) was diluted in chloroform. A mixture of 65% DOPC / 35% 34 
DOPS was used in the SLB, whose protocol had been optimized and already applied to other SLB-peptide studies29,63. 35 
When experiments required fluorescent SLB, DOPE-Atto647 was added to the lipids mixture to achieve a mass ratio of 36 
1/62500. This amount was determined to give an optimum fluorescence signal with the SAF technique. The following 37 
protocol was used for both fluorescent and non-fluorescent SLB. The lipid solution was stirred under nitrogen then left 38 
under vacuum (10 mbar) overnight to remove any trace of solvent. Dried lipids were resuspended in degassed “membrane 39 
buffer” (NaCl (100 mM), CaCl2 ● 3H2O (5 mM), Tris (10 mM), pH 7.4; Sigma Aldrich) and extruded at least 20 times 40 
through a porous membrane (0.1 µm pore size) to yield unilamellar vesicles with a homogeneous size distribution. The 41 
vesicles solution was then diluted in the membrane buffer to a concentration of 0.1 mg/mL and passed through a circulating 42 
flow system (0.25 mL/min) connected to the sample plate. A glass coverslip was glued on this sample plate after cleaning 43 
(cycle of Deconex11, ethanol and Milli-Q water in ultrasonic bath) and O2 plasma treatment in order to make the coverslip 44 
surface more hydrophilic. When the lipid vesicles adsorbed on this coverslip reached a critical concentration, vesicles 45 
fused to form a SLB. Non-disrupted vesicles were removed by extensive washing with the membrane buffer. Finally, SLB 1 
was let to stabilize for at least one hour with PBS (Sigma Aldrich) before any measurement.  2 
Monomeric Aβ (1-40), Aβ (1-42), Aβ (1-40)-HyliteTM Fluor 647 and Aβ (1-42)-HyliteTM Fluor 647 (Anaspec) were 3 
reconstituted in a 1% NH4OH solution, then immediately diluted in PBS. Non-labelled peptides were aliquoted at a 4 
concentration of 1 mg/mL and kept at -20°C until use (before 6 months of aging). Labelled peptides were aliquoted at the 5 
desired concentration and kept frozen until use.  6 
3.3 Fluorescence measurements  7 
Images of fluorescently labelled SLB or peptide were recorded using the custom-made microscope described previously. 8 
Both SAF and UAF signals are collected simultaneously. SAF channel only detects photons arising from the interface 9 
vicinity (~200 nm) while UAF channel detects photons emitted from the bulk solution (up to ~2.5 µm) by the use of 10 
confocal optics. The sample is constituted of a metal cell plate, whose volume is approximately 200 µL and samples were 11 
kept under constant flow rate of 0.25 mL/min with the desired peptide solution during measurements. Fast scanning of the 12 
sample area was performed via remote control of a mechanical moving frame.  13 
 14 
In order to analyze the mobility of the lipids inside the SLB, fluorescence correlation spectroscopy (FCS) was performed 15 
in combination with the supercritical angle collection. Briefly, the method consists to measure fluorescence signal 16 
fluctuations due to fluorophores motion within a defined detection volume and to correlate its value over an increasing 17 
time lap30,64. The radius of the SAF detection volume was calculated to be 550 ± 50 nm by measuring the intensity profile 18 
of fluorescent nanoparticles65. The persistence of the signal after an increasing delay was fitted with a 2-dimensional 19 
diffusion model66. Fitting allowed calculation of a diffusion coefficient (DL) which quantifies the lateral diffusion of lipid 20 
molecules (Equations 3, 4). The following equations introduce two diffusion coefficients (Da and Db), either to account 21 
for two leaflets moving differently or for errors that occur at higher τ values. These errors arise when the measuring time 22 
is too short to compensate all irregularities. However, short measuring time can be necessary when targeting a specific 23 
fluorescent aggregate moving along the SLB. 24 𝐺𝐺(𝜏𝜏) = 𝑎𝑎 ∙ 𝐺𝐺0 ∙ 11+4𝐷𝐷𝑎𝑎/𝜔𝜔02∙𝜏𝜏 + (1 − 𝑎𝑎) ∙ 𝐺𝐺0 ∙ 11+4𝐷𝐷𝑏𝑏/𝜔𝜔02∙𝜏𝜏 .                                            (3) 25 𝐷𝐷𝐿𝐿 = 𝑎𝑎 ∙ 𝐷𝐷𝑚𝑚 + (1 − 𝑎𝑎) 𝐷𝐷𝑏𝑏 .                                                                             (4) 26 
Where G is the autocorrelation value, G0 is the value at the y intercept, τ is the time delay for the autocorrelation and ω0 27 
being the radius of the detection volume. The signal was monitored during 1 minute for every FCS measurement. FCS 28 
curves were fitted with a Matlab program coded specifically.  29 
 30 
Abbreviations 31 
Aβ : Amyloid-Beta, FCS : fluorescence correlation spectroscopy, PBS : phosphate buffer saline, SAF : supercritical 32 
angle fluorescence, SLB : supported lipid bilayer, UAF : undercritical angle fluorescence. 33 
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